Intimation of submission of application to BSE Limited for reclassification of promoters
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Oxygenta Pharmaceutical has applied to BSE to reclassify four members of its promoter group — Sai Sudhakar Vankineni, Snigdha Vankineni, Sumanth Simha Vankineni, and Jhansi Rani Vankineni — from the 'Promoter Group' category to the 'Public' category under SEBI LODR Regulation 31A. Together, these four individuals hold 9,42,700 shares, representing roughly 2.55% of the company's equity. This is a procedural change in shareholding classification, not a sale of shares. The application awaits BSE approval.
The reclassification slightly reduces the effective promoter group stake by about 2.55%, marginally increasing the public float. This is a governance/administrative event with limited direct impact on stock price, though it signals that some members of the founding family no longer qualify as promoter group persons.